Printable version The Global HIV Vaccine Enterprise was conceived in 2003 to bring new focus, cooperation and expanded resources to HIV vaccine research. Since its inception, the Enterprise has formed an alliance of independent organizations that includes many of the leading AIDS vaccine research institutions in the world.
The Founding Members of the Enterprise include:
- Dr. Seth Berkley (International AIDS Vaccine Initiative/IAVI)
- Prof. Jean-François Delfraissy (French National Agency for Research on AIDS and Viral Hepatitis/ANRS)
- Dr. Anthony Fauci (National Institutes of Health, US Department of Health and Human Services/NIH/NIAID]
- Ms. Daisy Mafubelu (WHO-UNAIDS)
- Dr. Ruxandra Draghia-Akli (European Commission)
- Dr. Mark Walport (Wellcome Trust)
- Dr. Tachi Yamada and Dr. José Esparza (The Bill & Melinda Gates Foundation)
The Council is responsible for setting the strategic direction of the Enterprise in conjunction with the Secretariat.
Enterprise Council Members include:
- Dr. Rafi Ahmed (Emory University)
- Dr. David Cook (International AIDS Vaccine Initiative/IAVI)
- Dr. Kenneth Bertram (U.S. Military HIV Research Program/MHRP)
- Prof. Jean-François Delfraissy [National Agency for Research on AIDS and Viral Hepatitis in France (ANRS)]
- (Alternate: Prof. Yves Lévy)
- Dr. Ruxandra Draghia-Akli (European Commission)
- (Alternate: Dr. Alessandra Martini)
- Dr. Anthony Fauci [National Institutes of Health, US Department of Health and Human Services (NIH/NIAID)]
- (Alternate: Dr. Carl Dieffenbach)
- Ms. Cynthia Hallenbeck (Enterprise Secretary-Treasurer)
- Dr. Helene Gayle (Emeritus member; CARE)
- Madame Jeannette Kagame (First Lady of Rwanda)
- Dr. Peter Kim (Merck Research Laboratories)
- Dr. Catherine Hankins (WHO-UNAIDS)
- Dr. Malegapuru (William) Makgoba (University of KwaZulu-Natal)
- Prof. Yiming Shao (Chinese Center for Disease Control and Prevention)
- Dr. Mark Walport (Wellcome Trust)
- Mr. Mitchell Warren [AVAC: Global Advocacy for HIV Prevention]
- Dr. Tachi Yamada (the Bill & Melinda Gates Foundation)
- (Alternate: Dr. José Esparza, Acting Chair of the Enterprise Council)
The Board was established to govern the organization. The Directors adhere to a Conflict of Interest policy.
Enterprise Board Members include:
- Dr. David Cook, (International AIDS Vaccine Initiative)
- Prof. Jean François Delfraissy (National Agency for AIDS Research and Viral Hepatitis in France)
- Dr. Carl Dieffenbach (National Institutes of Health, US Department of Health and Human Services (NIH/NIAID)
- Dr. José Esparza (The Bill & Melinda Gates Foundation) (Acting President)
- Ms. Cynthia Hallenbeck (Enterprise Secretariat Board Secretary and Treasurer)
- COL. Nelson Michael (U.S. Military HIV Research Program)
- Mr. Mitchell Warren (AVAC: Global Advocacy for HIV Prevention)
The Science Committee provides strategic scientific guidance to the Secretariat. Members are drawn from stakeholder organizations and the broader scientific community.
Enterprise Science Committee Members include:
- Alan Aderem, Institute for Systems Biology
- Rafi Ahmed (Chair), Emory University
- Françoise Barré-Sinoussi, Institut Pasteur
- Dennis Burton, The Scripps Research Institute
- Larry Corey, Fred Hutchinson Cancer Research Center
- Barton Haynes, Duke University Medical Center
- Bette Korber, Los Alamos National Laboratory
- Andrew McMichael, University of Oxford
- Nelson Michael, MHRP
- Gary Nabel, National Institutes of Health, NIAID
- Michel Nussenzweig, Rockefeller University
- Giuseppe Pantaleo, University of Lausanne
- Louis Picker, Oregon Health & Science University
- Rino Rappuoli, Novartis Vaccines and Diagnostics
- Robin Shattock, St George's University of London
- Ralph Steinman, Rockefeller University
- Anna-Lise Williamson, University of Cape Town
Ex-officio Science Committee Members include:
- Carl Dieffenbach, National Institutes of Health, US Department of Health and Human Services (NIH/NIAID)
- Catherine Hankins, WHO-UNAIDS
- Wayne Koff, International AIDS Vaccine Initiative (IAVI)
- Yves Lévy, Hôpital Henri Mondor
- Manuel Romaris, European Commission
- Nina Russell, The Bill & Melinda Gates Foundation
